Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
 
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 10676 times
PR Category : Healthcare & Medicine
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Acc...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
LEAMS Education Launches Game-Changing Initiative Introducing IR4.0 and Robotics to make S... [8089-Views]
Get Ready to Swoon! As Most Awaited Party Anthem ‘CASANOVA' by Global Music Sensations YoY... [7876-Views]
Disney X Pandora: Born to Stand Out [7507-Views]
Tanishq Goes Traditional and Contemporary in Karama [5990-Views]
Ajmal Perfumes Exquisite Musk Collection – The Musk Silk Supreme [5912-Views]
Malabar Gold & Diamonds Announced Sparkling Summer Offers [4867-Views]
Introducing GRAFFABULOUS [4854-Views]
Dubai Health Authority Introduces Value-Based Healthcare for the Emirate [4551-Views]
Elevate Your Wardrobe This Eid with Travel-Chic Pieces from Revolve [3977-Views]
Malabar Group's M FIT Interior Decoration opens its new office in Dubai [3903-Views]
Damas Light the Way to a Brighter Future with New Hope Collection [3866-Views]
Majid Al Futtaim Opens its First Official CB2 Store in Dubai [3456-Views]
ESMOD Dubai 2022 Grads Step Out in Style [3456-Views]
Dubai Airports' Hajj Committee Finalises Preparations for Hajj Travellers from DXB [3337-Views]
Integrated Facilities Management Company Fabintech opens new office in Dubai [3313-Views]
Brazil to Continue Creating Opportunities with Results Achieved by Expo 2020 Participation [3079-Views]
GMG's Géant Reiterates Commitment to Single-Use Plastics Reduction in-Store [3075-Views]
Summer Saving Season is Back with Dubai Jewellery Group Dss Campaign – City of Gold Jewell... [3018-Views]
Jaguar TCS Racing Aim to Build on Positive Momentum in Marrakesh [2968-Views]
Sony Unveils New Gaming Gear Brand “INZONE,” to Maximise Performance and Ability with Upgr... [2956-Views]
Sharjah Child Friendly Office's Projects Ensure Schools meet Child-Friendly Standards, Not... [2952-Views]
Qatar brings Global Photography App, ‘Explorest,' to the Middle East [2952-Views]
Hitachi Energy and Petrofac to Collaborate in Growing Offshore Wind Market [2944-Views]
Carrefour Readies Customers For July 1 With A Wide Variety Of Reusable Bags [2886-Views]
Don't Miss Your Chance to Create Memorable F&B and Retail Experiences at Global Village's ... [2858-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Top Sections
 
Top Stories